BD Medical's trading volume on March 9 was $454 million, ranking 313th among US stocks that day.

On March 9, 2026, Becton Dickinson (BDX), a healthcare equipment company, had a trading volume of $454 million, ranking 313th among U.S. stocks that day, with a 1.96% increase from the previous day. The trading volume was 2.7652 million shares.

On March 9, 2026, Becton Dickinson (BDX) decreased by 0.99%, closing at $165.46. The stock has fallen 6.28% over the past 5 trading days, 6.24% for the entire March, 14.74% since the beginning of the year, and 27.92% over the past 52 weeks.

If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date (this also applies to listings of less than 1 month or fewer than 5 trading days).

Becton Dickinson released its Q1 FY2026 earnings report on February 9, 2026. Revenue for the period from October 1, 2025, to December 31, 2025, was $5.252 billion, a 1.63% increase year-over-year. Net income was $382 million, up 26.07% year-over-year.

Becton Dickinson Medical Devices Ltd. was incorporated in New Jersey in November 1906. The company is a global medical technology firm engaged in the development, manufacturing, and sales of various medical supplies, equipment, laboratory devices, and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the public. The company provides solutions focused on improving drug management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; enhancing drug delivery; assisting anesthesia care; strengthening infectious disease and cancer diagnostics; promoting cell research and applications; and supporting diabetes management.